018457862

NOVAVITA THERA

---

April 20, 2021

Trademark Summary

The trademark application NOVAVITA THERA was filed by Cytotheryx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 21, 2021, and it was registered by office on December 29, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Gene therapies, namely, in vivo and ex vivo vector treatments
  2. Lentiviral vector therapies
  3. Gene therapies for the treatment of rare diseases
  4. Gene therapies for hereditary tyrosinemia type 1
  5. Gene therapies for orphan disease
  6. Therapies for inborn errors of hepatic metabolism
  7. All of the aforesaid being pharmaceuticals, medical and veterinary preparations.